Results 31 to 40 of about 2,198,023 (191)

ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome

open access: yesMetabolism, 2018
Fructose malabsorption is a common digestive disorder in which absorption of fructose in the small intestine is impaired. An abnormality of the main intestinal fructose transporter proteins has been proposed as a cause for fructose malabsorption. However the underlying molecular mechanism for this remains unclear. In this study, we investigated whether
Ah-Reum, Oh   +8 more
openaire   +4 more sources

Irritable Bowel Syndrome: Diagnosis and Treatment [PDF]

open access: yes, 2003
Irritable bowel syndrome (IBS) is the most common functional disorder of the gastrointestinal tract. As a result of the lack of specific diagnostic testing and absence of circumscribed biology markers of the disease, its diagnosis is based on a myriad of
K, Marcellus Simadibrata   +3 more
core   +2 more sources

General practitioners believe that hypnotherapy could be a useful treatment for irritable bowel syndrome in primary care. [PDF]

open access: yes, 2004
BACKGROUND: Irritable bowel syndrome is a common condition in general practice. It occurs in 10 to 20% of the population, but less than half seek medical assistance with the complaint.
de Lusignan Simon   +8 more
core   +2 more sources

Acupuncture for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Randomized Clinical Trial.

open access: yesJAMA Netw Open, 2022
Importance Acupuncture is a promising therapy for irritable bowel syndrome (IBS), but the use of subjective scales as an assessment is accompanied by high placebo response rates. Objectives To preliminarily test the feasibility of ...
Qi LY   +8 more
europepmc   +3 more sources

Acupuncture for irritable bowel syndrome:primary care based pragmatic randomised controlled trial [PDF]

open access: yes, 2012
Background: Acupuncture is used by patients as a treatment for irritable bowel syndrome (IBS) but the evidence on effectiveness is limited. The purpose of the study was to evaluate the effectiveness of acupuncture for irritable bowel syndrome in primary ...
Bloor, Karen   +27 more
core   +2 more sources

Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea

open access: yesFrontiers in Pharmacology, 2021
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis, which affects approximately 4% of the global population. The Rome IV criteria define IBS as chronic or recurrent abdominal pain associated with altered bowel habits.
Esther Colomier   +5 more
doaj   +1 more source

Correlation between 5-HT and Diarrhea-type Irritable Bowel Syndrome and Regulation by Traditional Chinese Medicine [PDF]

open access: yes, 2023
5-hydroxytryptamine (5-HT) is an important brain intestinal peptide that affects gastrointestinal function in patients with diarrhea-type irritable bowel syndrome.
SU Haixia, FU Zhaoyuan, GAO Yongze, YU Rongrong, ZHONG Jianchun
core   +2 more sources

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. The SEPD perspective

open access: yesRevista Española de Enfermedades Digestivas, 2017
Functional gut disorders, including diarrhea-predominant irritable bowel syndrome, are highly prevalent conditions worldwide that significantly impact health economy and patient quality of life, yet lacking fully satisfactory therapeutic options.
Vera, Isabel, Júdez, Javier
openaire   +4 more sources

Moxibustion for diarrhea-predominant irritable bowel syndrome

open access: yesMedicine, 2021
Abstract Background: Irritable bowel syndrome (IBS) is commonly accompanied by intestinal dysfunction, and diarrhea-predominant irritable bowel syndrome accounts for approximately 23.4% of all cases of IBS. The purpose of this study was to evaluate the efficacy and safety of moxibustion in the treatment of diarrhea ...
Tiantian Dong   +6 more
openaire   +2 more sources

Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome

open access: yesEuropean Journal of Histochemistry, 2020
Our objectives are to demonstrate whether the kynurenine pathway is activated in diarrhea-type irritable bowel syndrome (IBS-D) patients, and whether the neurotoxic metabolite quinolinic acid (QUIN) is out of balance with the neuroprotective metabolite kynurenic acid (KYNA), and further explore whether this can lead to increase of N-methyl D-aspartate ...
Pingping Li   +7 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy